X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Promoting global vaccine equity while protecting innovation

By Megan Van Etten  |    July 15, 2021
America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The...   Read More

New PhRMA Scholars program provides support to exceptional college-bound DC students

By Rachel Weissman  |    June 18, 2021
As part of our continued efforts to promote diversity, equity and inclusion, we’re excited to announce the PhRMA Scholars program and the exceptional students who received this year’s awards.    Read More

Creating a new patient risk paradigm in American health care

By Guest Contributor  |    May 18, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

The FDA Office of Minority Health and Health Equity: Working to advance health equity through diversity in research

By Guest Contributor  |    May 12, 2021
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

A conversation with Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. on improving vaccine confidence in communities of color

By Stephen J. Ubl  |    May 5, 2021
The COVID-19 pandemic exposed and often exacerbated the significant systemic health inequities that underserved communities have faced for many years. Black Americans have been particularly...   Read More

PhRMA member companies share how they are improving clinical trial diversity

By Dr. Freda Lewis-Hall  |    April 14, 2021
As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial...   Read More

Diversifying clinical trials and fighting disease requires equity and trust

By Rebecca Marklund  |    April 12, 2021
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and...   Read More

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

By Abigail Lore  |    March 5, 2021
Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation....   Read More

Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

By Courtney Christian  |    January 28, 2021
Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates